Need reading glasses? New FDA-approved eye drops could replace them, research suggests

FILE: Woman applying eye drops. (Credit: Getty Images)

(WJW) — A new prescription eye drop that could help many people stop their readers is now on the market.

Vuity, approved by the Food and Drug Administration in October, was developed to treat presbyopia, or age-related blurred near vision, according to a statement from biopharmaceutical company AbbVie.

Get daily news, weather, breaking news and alerts straight to your inbox! Sign up for abc27 newsletters here!

According to the release, presbyopia affects most adults after age 40 — nearly 128 million Americans — making it harder to see or read up close.

The drops are intended for daily use and start working in about 15 minutes. The effects last up to six hours.

The drops utilize the eye’s ability to reduce pupil size, which improves near vision without affecting distance vision.

“Most adults deal with presbyopia or near vision difficulties as we age. From around the age of 40, many find themselves using reading glasses, holding text more away or even increasing the font size and lighting of the screens to try to see more clearly,” said Dr. Michael Severino, vice president and president of AbbVie.

According to a AbbVie October Releasethe clinical trial involved 750 people between the ages of 40 and 55. A “statistically significant proportion” of those treated with the drops gained the ability to read three extra lines on a read load.

The most common side effects, according to the release, are headaches and red eyes.

Sarah C. Figueiredo